✦ LIBER ✦

The importance of angiogenesis markers in the outcome of patients with diffuse large B cell lymphoma: a retrospective study of 97 patients

✍ Scribed by Kristen N. Ganjoo; Annette M. Moore; Attilio Orazi; Joy A. Sen; Cynthia S. Johnson; Caroline S. An

Publisher: Springer-Verlag
Year: 2007
Tongue: English
Weight: 460 KB
Volume: 134
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-007-0294-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Retrospective analysis of primary gastri

Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan

✍ Tsutomu Tanaka; Kazuyuki Shimada; Kazuhito Yamamoto; Yoshiki Hirooka; Yasumasa N 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 149 KB

Multicentre phase II study of CyclOBEAP

Multicentre phase II study of CyclOBEAP plus rituximab in patients with diffuse large B-cell lymphoma

✍ Nozomi Niitsu; Mika Kohri; Yuki Hagiwara; Ken Tanae; Naoki Takahashi; Masami Bes 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 1 views

## Abstract The R‐CHOP regimen has been found to improve the outcome of diffuse large B‐cell lymphoma (DLBCL). However, it does not provide a satisfactory treatment outcome in the high‐risk group. We previously administered the CyclOBEAP regimen to patients with DLBCL, and reported its safety and e

Clinicopathologic features of the nine p

Clinicopathologic features of the nine patients with primary diffuse large B cell lymphoma of the breast

✍ Mesut Seker; Ahmet Bilici; Basak Oven Ustaalioglu; Burçak Yilmaz; Banu Ozturk; A 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 190 KB

Importance of maintaining the relative d

Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-cell lymphoma

✍ Tsuneaki Hirakawa; Hiroki Yamaguchi; Norio Yokose; Seiji Gomi; Koiti Inokuchi; K 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 166 KB

Concomitant statin use does not impair t

Concomitant statin use does not impair the clinical outcome of patients with diffuse large B cell lymphoma treated with rituximab-CHOP

✍ Panagiotis Samaras; Helen Heider; Sarah R. Haile; Ulf Petrausch; Niklaus G. Scha 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 154 KB

Anti-lymphoma effect of naproxen and ind

Anti-lymphoma effect of naproxen and indomethacin in a patient with relapsed diffuse large B-cell lymphoma

✍ Kentaro Yoshinaga; Masanao Teramura; Koji Iwabe; Shoko Kobayashi; Michihiko Masu 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views